Winter, A.; Nepper, P.; Hermann, M.; Bayer, F.; Riess, S.; Salem, R.; Hlavicka, J.; Prinzing, A.; Hecker, F.; Holubec, T.;
et al. Glibenclamide Serves as a Potent Vasopressor to Treat Vasoplegia After Cardiopulmonary Bypass and Reperfusion in a Porcine Model. Int. J. Mol. Sci. 2025, 26, 4040.
https://doi.org/10.3390/ijms26094040
AMA Style
Winter A, Nepper P, Hermann M, Bayer F, Riess S, Salem R, Hlavicka J, Prinzing A, Hecker F, Holubec T,
et al. Glibenclamide Serves as a Potent Vasopressor to Treat Vasoplegia After Cardiopulmonary Bypass and Reperfusion in a Porcine Model. International Journal of Molecular Sciences. 2025; 26(9):4040.
https://doi.org/10.3390/ijms26094040
Chicago/Turabian Style
Winter, Andreas, Pascal Nepper, Marcus Hermann, Franziska Bayer, Stephanie Riess, Razan Salem, Jan Hlavicka, Anatol Prinzing, Florian Hecker, Tomas Holubec,
and et al. 2025. "Glibenclamide Serves as a Potent Vasopressor to Treat Vasoplegia After Cardiopulmonary Bypass and Reperfusion in a Porcine Model" International Journal of Molecular Sciences 26, no. 9: 4040.
https://doi.org/10.3390/ijms26094040
APA Style
Winter, A., Nepper, P., Hermann, M., Bayer, F., Riess, S., Salem, R., Hlavicka, J., Prinzing, A., Hecker, F., Holubec, T., Zacharowski, K., Walther, T., & Emrich, F.
(2025). Glibenclamide Serves as a Potent Vasopressor to Treat Vasoplegia After Cardiopulmonary Bypass and Reperfusion in a Porcine Model. International Journal of Molecular Sciences, 26(9), 4040.
https://doi.org/10.3390/ijms26094040
